STSP-0601

STSP-0601 · Staidson (Beijing) Biopharmaceuticals Co., Ltd

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for STSP-0601, covering 2024-01-02 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients [Phase 3]